139 related articles for article (PubMed ID: 1876187)
21. Association of malignant glioma with the human leukocyte antigen, HLA-A24(9).
Nitta T; Ebato M; Sato K
Neurosurg Rev; 1994; 17(3):211-5. PubMed ID: 7838400
[TBL] [Abstract][Full Text] [Related]
22. HLA antigens and cervical carcinoma.
Wank R; Schendel DJ; Thomssen C
Nature; 1992 Mar; 356(6364):22-3. PubMed ID: 1538774
[No Abstract] [Full Text] [Related]
23. Genetic features of Mexican women predisposing to cancer of the uterine cervix.
Silva B; Vargas-Alarcón G; Zúñiga-Ramos J; Rodríguez-Reyna TS; Hernández-Martinez B; Osnaya N; Kofman S; Torres-Lobatón A; Granados J
Hum Pathol; 1999 Jun; 30(6):626-8. PubMed ID: 10374768
[TBL] [Abstract][Full Text] [Related]
24. Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line.
Schiffenbauer J; Didier DK; Klearman M; Rice K; Shuman S; Tieber VL; Kittlesen DJ; Schwartz BD
J Immunol; 1987 Jul; 139(1):228-33. PubMed ID: 3584986
[TBL] [Abstract][Full Text] [Related]
25. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Apple RJ; Becker TM; Wheeler CM; Erlich HA
J Natl Cancer Inst; 1995 Mar; 87(6):427-36. PubMed ID: 7861462
[TBL] [Abstract][Full Text] [Related]
26. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.
Hilders CG; Houbiers JG; Krul EJ; Fleuren GJ
Am J Clin Pathol; 1994 Jan; 101(1):5-12. PubMed ID: 7506480
[TBL] [Abstract][Full Text] [Related]
27. Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel.
Awad J; Navarrete C; Festenstein H
Tissue Antigens; 1987 Jan; 29(1):55-9. PubMed ID: 3473746
[TBL] [Abstract][Full Text] [Related]
28. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
Gogolin KJ; Spielman RS
Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
[TBL] [Abstract][Full Text] [Related]
29. Alloreactive T-cell clones raised in an HLA-B/D crossing-over family dissect HLA-DR5 and HLA-DQw3 subtypes.
Eiermann TH; Winkelmann S; Ballas M; Wölpl A; Goldmann SF
Hum Immunol; 1990 Oct; 29(2):117-30. PubMed ID: 1701168
[TBL] [Abstract][Full Text] [Related]
30. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
Peano G; Menardi G; Ponzetto A; Fenoglio LM
Arch Intern Med; 1994 Dec 12-26; 154(23):2733-6. PubMed ID: 7993158
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
32. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
[TBL] [Abstract][Full Text] [Related]
34. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
36. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
Kratz LE; Boughman JA; Needleman BW
Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
[TBL] [Abstract][Full Text] [Related]
37. Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.
Radka SF; Scott RG; Stewart SJ
Hum Immunol; 1987 Apr; 18(4):287-300. PubMed ID: 2437090
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women.
Jiang J; Li N; Shen Y; Liu J; Liu L; Du J; Lei Y; Wen Y; Yang L; Guo L; Zhang K; Qiang F; Wang S; Hu Z; Dai M; Shen H
Gynecol Oncol; 2013 May; 129(2):401-5. PubMed ID: 23428460
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
40. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles.
Wank R; Meulen JT; Luande J; Eberhardt HC; Pawlita M
Lancet; 1993 May; 341(8854):1215. PubMed ID: 8098101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
